Terminated clinical registry of patients with chronic myeloid leukaemia (CML) for the Arab Leukaemia Network.
start of the project: 10/2012
end of the project: 12/2014
Arab Leukaemia Network (ALN) is an initiative taken by key opinion leaders in the Middle East, covering the entire region. ALN vision is to reduce the burden of leukaemia on individual, societal and governmental levels by creating an e-platform which would collect research records on leukaemia, publish scientific results and clinical outcomes, share knowledge, and develop protocols with the aim to improve not only treatment outcomes, but also patients’ quality of life and survival.
- Expert guarantor: Prof. Mohamed Azzazi, M.D. (Ain Shams University, Medical School, Cairo, Egypt)
- Partners: 5 haemato-oncology centres in Middle Eastern countries (Egypt and the United Arab Emirates)
- Brief overview of results: Azzazi MO, Fahmy O, Mattar M, et al. Second Report of Arab Leukemia Net (ALN) Registry for Chronic Myeloid Leukemia (CML) in the Middle East & North Africa Region (AFME). Epidemiology of CML and Additional Chromosomal Abnormalities (ACAs) in Egypt, Multicenter Results. Blood 2014; 124(21): 5539.
- Anaesthesiology, intensive care medicine
- Cardiology, angiology
- Diabetology, dietetics
- Educational projects
- Emergency medicine, toxicology
- Endocrinology, metabolism
- Gastroenterology, hepatology
- Haematology, haematological oncology
- Immunology, allergology
- Medical genetics
- Nephrology
- Neurology, neurosurgery
- Nursing care
- Obstetrics, gynaecology
- Oncology, radiotherapy
- Ophthalmology
- Paediatrics, neonatology
- Pathology, laboratory medicine
- Pulmonary medicine
- Rheumatology, physiotherapy
- Screening programmes
- Surgery, traumatology, orthopaedics
- Urology